Vera Therapeutics, Inc.
US ˙ NasdaqGM ˙ US92337R1014

SecurityVERA / Vera Therapeutics, Inc.
InstitutionAlgert Global Llc
Latest Disclosed Ownership36,310 shares
Latest Disclosed Value $ 1,461
Algert Global Llc reports 44.02% decrease in ownership of VERA / Vera Therapeutics, Inc.

On May 14, 2026 - Algert Global Llc filed a 13F-HR form disclosing ownership of 36,310 shares of Vera Therapeutics, Inc. (US:VERA) valued at $1,460,751 USD as of March 31, 2026. The entity filed a previous 13F-HR on February 17, 2026 disclosing 64,868 shares of Vera Therapeutics, Inc.. This represents a change in shares of -44.02% during the quarter. The current value of the position is $1,172,450 USD.

Institutional Ownership: 13F and NPORT Filings

The Security and Class in the table below are shown exactly as filed by the investor. We do our best to track continuity of investments through acquisitions, and this will be reflected in the table as changes in names. In addition to descriptive data, performance of the investment is shown over time. To calculate quarterly performance, we first calculate cost basis of the shares purchased during the quarter, then use that to calculate gross profit. Quarterly return is Gross Profit / Starting Portfolio value.

Note that cost basis is calculated and stored in thousands, so small quarterly changes in shares frequently result in a cost basis of zero.

Upgrade to unlock premium data and export to Excel .

Disclosed Equity Positions (from 13F/NPORT Filings)
File
Date		 Effective
Date		Form Security Class ID Avg Price
Paid (Est)		 Reported
Shares		 ΔShares ΔShares
(%)		 Reported
Value
(x1000)		 ΔValue
(%)		 Alloc
(%)		 ΔAlloc ΔAlloc (%) Cost Basis
(x1000)		 Unrealized
Gain/Loss
(x1000)
2026-05-14 2026-03-31 13F VERA THERAPEUTICS CL A 92337R101 36,310 -28,558 -44.02 1 -66.67 0.0220
2026-02-17 2025-12-31 13F VERA THERAPEUTICS CL A 92337R101 64,868 -228,520 -77.89 3 -62.50 0.0512
2025-11-14 2025-09-30 13F VERA THERAPEUTICS CL A 92337R101 293,388 39,235 15.44 9 60.00 0.1427
2025-08-14 2025-06-30 13F ERA THERAPEUTICS CL A 92337R101 254,153 184,143 263.02 6 400.00 0.1254
2025-05-13 2025-03-31 13F VERA THERAPEUTICS CL A 92337R101 70,010 31,460 81.61 2 0.00 0.0416
2025-02-14 2024-12-31 13F VERA THERAPEUTICS CL A 92337R101 38,550 15,386 66.42 2 0.00 0.0384
2024-11-12 2024-09-30 13F VERA THERAPEUTICS CL A 92337R101 23,164 5,910 34.25 1 0.0275
2024-08-15 2024-06-30 13F VERA THERAPEUTICS CL A 92337R101 17,254 4,834 38.92 1 0.0208
2024-05-15 2024-03-31 13F VERA THERAPEUTICS CL A 92337R101 12,420 12,420 1 0.0210
Legend
Shares
The total number of shares held by the institution at the end of the reporting period (the effective date). This is provided in the filing.
Value
The total value of the shares as of the effective date. This is provided in the filing.
Avg. Share Price
The weighted average share price of the shares held by the institution. We use FIFO accounting to determine this price
Class
This is the security class as indicated by the filer. There are a variety of values for this field. Common values include "EC" = equity common, "EP" - equity preferred
Allocation (%)
The percent of the institution's portfolio that this position represents. This is provided in NPORT filings. For 13F filings, we calculate it.
Change in Allocation
The change in allocation from the prior reporting period. This is calculated as current allocation - prior allocation.
Change in Allocation (%)
The percent change in allocation from the prior reporting period. This is calculated as (current allocation - prior allocation) / prior allocation.
Cost Basis
The total cost of the shares held. This is calculated as reported shares * avg. share price
Unrealized Gain/Loss
This is the market value of the position as of the effective date minus the cost basis.